Life Sciences Executive Search.
From pharma and biotech to medical devices, diagnostics and pharma services, we place the leaders who turn science into treatments patients can access. Every search is retained, partner-led and powered by proprietary talent intelligence.
What we cover.
Life sciences is not one market. A clinical-stage biotech and a global CDMO need very different leaders, and the talent pools barely overlap. We work across the whole value chain, from discovery to patient delivery.
Pharma & Biopharma.
Global pharmaceutical and biopharmaceutical organisations. Commercial, medical, regulatory and operational leadership across the full product lifecycle.
Biotech & Emerging Therapeutics.
Clinical-stage and pre-commercial biotech, cell and gene therapy, and venture and PE-backed businesses building leadership teams for the first time.
Medical Devices & MedTech.
Devices, surgical technology, implantables and connected health hardware, where regulatory rigour meets commercial and engineering leadership.
Diagnostics & Life Science Tools.
In-vitro diagnostics, molecular testing, laboratory instruments, reagents and consumables. Leaders who understand both the science and the channel.
CRO, CDMO & Pharma Services.
Contract research and manufacturing, clinical services and commercialisation partners. Businesses that win on capability, capacity and client trust.
Digital Health & Health Tech.
Software, data and AI-enabled businesses working across the health system, where life sciences expertise meets genuine technology leadership.
Leadership roles we recruit.
We operate exclusively at Director to C-suite level. Across life sciences, the roles we are most frequently retained to fill include:
For large-scale leadership build-outs or transformation projects, our Exec-Project service provides a dedicated, scalable search solution. For senior leaders needed on a flexible or interim basis, our Interim & Fractional Leadership practice delivers impact immediately. For hiring below Director level, PW Talent extends the same sector expertise across the full talent spectrum.
The science needs the right people behind it.
Our world of difference.
24/7 AI-sourcing, powered by PW Edge.
Every search is powered by PW Edge, our proprietary talent intelligence platform. Nine intelligence modules, 28+ live data sources, dual-model AI. In a sector where the right leader may sit in a different therapeutic area, a different modality or a different country entirely, that reach matters more than a database of the usual names.
Explore PW Edge →Cross-sector perspective.
Our partners have built leadership teams across industrials, technology, consumer and financial services as well as life sciences. As the industry absorbs data, AI and advanced manufacturing, the best candidate is increasingly not the obvious one, and we know where to look.
Retained. Never contingent.
Every search gets dedicated resource, a defined methodology and a named partner who owns the outcome from brief to placement. No multi-agency contingency, and no handing you to a junior once the pitch is won.
Built for precision. Guaranteed.
Brief to shortlist in 45 days, hit on 95% of mandates. Psychometric profiling via Assessio AI. Every placement guaranteed for 6 months at Director level and 12 months at VP and above. 92% of our clients return.
What triggers a leadership search.
The businesses we work with rarely come to us because everything is going smoothly. There is usually a catalyst. The five we see most often are:
Funding rounds and the move to clinic.
A Series B, a first-in-human trial or a pivotal readout changes what a business needs at the top. Founders and scientific teams need commercial, clinical and regulatory leadership that has taken an asset through the next stage before.
Commercial launch readiness.
Moving from development to first commercial launch is the single biggest capability shift a life sciences business makes, and it demands market access, medical affairs and commercial leaders who have done it.
M&A, carve-outs and PE investment.
Consolidation across pharma services, devices and diagnostics creates urgency to build or rebuild leadership teams that can deliver an investment thesis and stand up to diligence.
Regulatory and quality pressure.
New regulatory frameworks, an inspection finding or a market withdrawal put quality and regulatory leadership under scrutiny, and these are among the hardest roles in the sector to fill well.
Data, AI and manufacturing transformation.
As businesses adopt AI in discovery, digitise clinical operations and modernise manufacturing, they need leaders who genuinely bridge science and technology rather than one or the other.
The life sciences talent landscape.
Few sectors are changing their leadership requirements as quickly as life sciences, and the talent pool has not kept pace.
The patent cliff is reshaping priorities.
With significant revenue exposure as major products lose exclusivity, large pharma is hiring for business development, licensing and portfolio leadership, while simultaneously running cost programmes. Those two demands need very different leaders.
Biotech funding is selective again.
Capital is available but concentrated. Clinical-stage businesses need leadership teams credible enough to raise, which puts a premium on executives with a demonstrable track record of getting assets through development and to market.
AI is changing the top of the org chart.
Machine learning in discovery, digital clinical trials and AI-assisted regulatory work all require leaders who can hold science and technology together. That profile is genuinely scarce, and it is being competed for by technology companies as well as pharma.
Advanced modalities have specialised the talent pool.
Cell and gene therapy, radiopharmaceuticals and ADCs need manufacturing, CMC and quality leaders with modality-specific experience. There are very few of them, and they are rarely on the market.
Market access has become a boardroom function.
Pricing pressure, HTA reform and payer scrutiny mean market access and health economics leadership now shapes commercial strategy rather than supporting it, and is increasingly represented at executive level.
Regulatory and quality talent is the tightest market.
Evolving device regulation and rising inspection expectations have made senior regulatory and quality leaders among the hardest hires in the sector, particularly those able to operate across multiple jurisdictions.
We track these shifts through our client work, our network across the sector, and ongoing research through PW Edge. Every search is informed by where the industry is heading, not just where it has been.
What our clients say.
Frequently asked questions.
Life sciences news.
Live headlines from across pharma, biotech and healthcare innovation, updated automatically.
Let's find your next leader.
Whether you are building a first commercial team, preparing for launch, integrating an acquisition or strengthening regulatory and quality leadership, we would welcome a conversation. No commitment, just a genuine view of your market and the leaders in it.
Get in touch